Le Lézard
Classified in: Health
Subjects: NPT, LAW, LEG, EXE, WOM, AVO

ACLJ: Supreme Court Decision Backing Pro-Life Pregnancy Centers Brings An End To The "Abortion Distortion" Factor


WASHINGTON, June 26, 2018 /PRNewswire-USNewswire/ -- The American Center for Law and Justice (ACLJ), which filed a critical amicus brief in the case ? said today's 5-4 decision by the U.S. Supreme Court backing pro-life advocates represents "a significant victory for pro-life pregnancy centers" and the decision represents "a tremendous victory for the First Amendment."

ACLJ: The court clearly understood that First Amendment free speech rights cannot be applied differently ? one set of rules for those protecting the right-to-life, and another for those promoting abortion.

Today's Supreme Court decision reverses a decision by the U.S. Court of Appeals for the Ninth Circuit ? concluding that the challengers are likely to succeed on the merits of their claim that the California Reproductive FACT Act violates the First Amendment.

"This is a significant victory for pro-life pregnancy centers and the decision represents a tremendous victory for the First Amendment," said Jay Sekulow, Chief Counsel of the ACLJ. "This decision brings an end to the troubling abortion distortion factor. The court clearly understood that First Amendment free speech rights cannot be applied differently ? one set of rules for those protecting the right-to-life, and another for those promoting abortion."

Under the California law, licensed pregnancy centers were required to post notices about abortion services. It also required unlicensed centers to inform clients that they are not medical facilities.

In today's decision on NIFLA v. Becerra, the court sent the case back to the lower court for further consideration.

The ACLJ has been very involved in defending the rights of pro-life pregnancy centers.  It filed an amicus brief with the Supreme Court in this case.  The ACLJ also filed suit on behalf of three crisis pregnancy centers ? LivingWell Medical Clinic, Pregnancy Care Center of the North Coast, and Confidence Pregnancy Center ? challenging the California law.  The ACLJ also filed a Petition For Writ of Certiorari ? asking the high court to take our case.

Led by Chief Counsel Jay Sekulow, the American Center for Law and Justice (ACLJ), focusing on constitutional law, is based in Washington, D.C. and is online at www.aclj.org.

MEDIA CONTACTS: 
For Print: Gene Kapp (757) 575-9520
For Broadcast:  Anna Hutsell or Janna Dawson (770) 813-0000

SOURCE American Center for Law and Justice


These press releases may also interest you

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with platinum-containing chemotherapy as neoadjuvant treatment, then...

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...

at 06:30
The collagen water market is booming thanks to the growing popularity of health and beauty products. Consumers are more interested in skincare and healthy eating, which is driving manufacturers to create collagen-infused drinks and cosmetics. A new...

at 06:30
Viavi Solutions Inc. (VIAVI)  today announced it has participated in the 2024 RIC Forum, March 26-28, in Dallas, Texas. The company contributed its TeraVM RIC Test and TM500 Network Tester to multiple demonstrations, building on collaborations at MWC...

at 06:30
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively...



News published on and distributed by: